EVGN vs ZCMD
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
EVGN shows bearish fundamentals based on deterministic rules. Financial strength is weak (F-Score 1/9). Concerns include weak profitability or high valuation.
ZCMD presents a classic 'value trap' profile, characterized by a stable Piotroski F-Score of 6/9 and an exceptionally strong balance sheet (zero debt, 11.11 current ratio) contrasted against catastrophic operational decay. While the stock trades at a deep discount to book value (P/B 0.32), the company is suffering from severe revenue contraction (-23.2% YoY) and an unsustainable operating margin of -92%. The long-term price performance is devastating, with a 98.6% decline over five years, suggesting the market has fundamentally lost confidence in the business model despite the liquidity cushion.
Compare Another Pair
Related Comparisons
EVGN vs ZCMD: Head-to-Head Comparison
This page compares Evogene Ltd. (EVGN) and Zhongchao Inc. (ZCMD) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.